Anti-APOA5/ APOAV/ RAP3 functional antibody

Anti-APOA5/ APOAV/ RAP3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to APOA5/APOA5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0671-Ab-1/ GM-Tg-hg-SE0671-Ab-2Anti-Human APOA5 monoclonal antibodyHuman
GM-Tg-rg-SE0671-Ab-1/ GM-Tg-rg-SE0671-Ab-2Anti-Rat APOA5 monoclonal antibodyRat
GM-Tg-mg-SE0671-Ab-1/ GM-Tg-mg-SE0671-Ab-2Anti-Mouse APOA5 monoclonal antibodyMouse
GM-Tg-cynog-SE0671-Ab-1/ GM-Tg-cynog-SE0671-Ab-2Anti-Cynomolgus/ Rhesus macaque APOA5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0671-Ab-1/ GM-Tg-felg-SE0671-Ab-2Anti-Feline APOA5 monoclonal antibodyFeline
GM-Tg-cang-SE0671-Ab-1/ GM-Tg-cang-SE0671-Ab-2Anti-Canine APOA5 monoclonal antibodyCanine
GM-Tg-bovg-SE0671-Ab-1/ GM-Tg-bovg-SE0671-Ab-2Anti-Bovine APOA5 monoclonal antibodyBovine
GM-Tg-equg-SE0671-Ab-1/ GM-Tg-equg-SE0671-Ab-2Anti-Equine APOA5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0671-Ab-1/ GM-Tg-hg-SE0671-Ab-2; GM-Tg-rg-SE0671-Ab-1/ GM-Tg-rg-SE0671-Ab-2;
GM-Tg-mg-SE0671-Ab-1/ GM-Tg-mg-SE0671-Ab-2; GM-Tg-cynog-SE0671-Ab-1/ GM-Tg-cynog-SE0671-Ab-2;
GM-Tg-felg-SE0671-Ab-1/ GM-Tg-felg-SE0671-Ab-2; GM-Tg-cang-SE0671-Ab-1/ GM-Tg-cang-SE0671-Ab-2;
GM-Tg-bovg-SE0671-Ab-1/ GM-Tg-bovg-SE0671-Ab-2; GM-Tg-equg-SE0671-Ab-1/ GM-Tg-equg-SE0671-Ab-2
Products NameAnti-APOA5 monoclonal antibody
Formatmab
Target NameAPOA5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-APOA5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0671-Ag-1Recombinant multi-species APOA5/ APOAV/ RAP3 protein
    ORF Viral VectorpGMLPm001817mouse Apoa5 Lentivirus plasmid
    ORF Viral VectorvGMLPm001817mouse Apoa5 Lentivirus particle


    Target information

    Target IDGM-SE0671
    Target NameAPOA5
    Gene ID116519,66113,140638,696484,489393,101085400,538914,100071101
    Gene Symbol and Synonyms1300007O05Rik,apo-AV,apoA-V,APOA5,APOAV,RAP3
    Uniprot AccessionQ6Q788,Q9QUH3
    Uniprot Entry NameAPOA5_HUMAN,APOA5_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000110243
    Target ClassificationN/A

    The target: APOA5, gene name: APOA5, also named as APOAV, RAP3. The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.